Yifeng Pharmacy Chain Co., Ltd. (SHA: 603939)
China
· Delayed Price · Currency is CNY 19.08
-0.92 (-4.60%)
Sep 6, 2024, 3:00 PM CST
Yifeng Pharmacy Chain Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 23,048 | 22,078 | 19,382 | 14,807 | 12,813 | 9,977 | Upgrade
|
| Other Revenue | 595.72 | 510.66 | 504.62 | 519 | 331.15 | 299.35 | Upgrade
|
| Revenue | 23,644 | 22,588 | 19,886 | 15,326 | 13,145 | 10,276 | Upgrade
|
| Revenue Growth (YoY) | 8.25% | 13.59% | 29.75% | 16.60% | 27.91% | 48.66% | Upgrade
|
| Cost of Revenue | 14,661 | 14,030 | 12,082 | 9,184 | 8,183 | 6,284 | Upgrade
|
| Gross Profit | 8,983 | 8,558 | 7,805 | 6,143 | 4,961 | 3,992 | Upgrade
|
| Selling, General & Admin | 6,725 | 6,450 | 5,782 | 4,717 | 3,705 | 3,120 | Upgrade
|
| Research & Development | 40.56 | 33.55 | 25.31 | 15.64 | 8.31 | 5.37 | Upgrade
|
| Other Operating Expenses | 85.35 | 57.59 | 59.1 | 28.18 | 49.95 | 32.41 | Upgrade
|
| Operating Expenses | 6,854 | 6,546 | 5,877 | 4,765 | 3,770 | 3,162 | Upgrade
|
| Operating Income | 2,129 | 2,012 | 1,928 | 1,377 | 1,191 | 830.53 | Upgrade
|
| Interest Expense | -183.37 | -160.53 | -165.21 | -168.99 | -186.08 | -45.79 | Upgrade
|
| Interest & Investment Income | 146.79 | 135.66 | 80.08 | 98.51 | 87.92 | 33.31 | Upgrade
|
| Other Non Operating Income (Expenses) | -26.3 | -18.94 | -12.81 | -10.03 | -13.94 | -14.81 | Upgrade
|
| EBT Excluding Unusual Items | 2,066 | 1,969 | 1,830 | 1,297 | 1,079 | 803.23 | Upgrade
|
| Gain (Loss) on Sale of Assets | 41.26 | 41.82 | 23.17 | 6.85 | 0.32 | -0.88 | Upgrade
|
| Asset Writedown | -12.73 | -12.73 | -10.33 | -1.43 | -1.58 | -0.3 | Upgrade
|
| Other Unusual Items | 42.82 | 39.87 | 34.99 | 35.49 | 49.39 | 12.24 | Upgrade
|
| Pretax Income | 2,137 | 2,038 | 1,877 | 1,338 | 1,127 | 814.3 | Upgrade
|
| Income Tax Expense | 495.25 | 456.66 | 454.06 | 347.16 | 287.92 | 205.41 | Upgrade
|
| Earnings From Continuing Operations | 1,642 | 1,581 | 1,423 | 990.75 | 839.44 | 608.88 | Upgrade
|
| Minority Interest in Earnings | -137.59 | -168.95 | -161.58 | -102.86 | -95.92 | -65.13 | Upgrade
|
| Net Income | 1,505 | 1,412 | 1,262 | 887.88 | 743.52 | 543.75 | Upgrade
|
| Net Income to Common | 1,505 | 1,412 | 1,262 | 887.88 | 743.52 | 543.75 | Upgrade
|
| Net Income Growth | 8.20% | 11.90% | 42.12% | 19.42% | 36.74% | 30.58% | Upgrade
|
| Shares Outstanding (Basic) | 1,207 | 1,210 | 1,202 | 1,193 | 1,157 | 1,152 | Upgrade
|
| Shares Outstanding (Diluted) | 1,207 | 1,210 | 1,211 | 1,203 | 1,157 | 1,153 | Upgrade
|
| Shares Change (YoY) | -0.48% | -0.09% | 0.70% | 4.01% | 0.31% | 3.61% | Upgrade
|
| EPS (Basic) | 1.25 | 1.17 | 1.05 | 0.74 | 0.64 | 0.47 | Upgrade
|
| EPS (Diluted) | 1.25 | 1.17 | 1.04 | 0.74 | 0.64 | 0.47 | Upgrade
|
| EPS Growth | 8.71% | 12.00% | 41.13% | 14.81% | 36.32% | 26.03% | Upgrade
|
| Free Cash Flow | 4,261 | 3,884 | 3,333 | 1,322 | 1,747 | 503.95 | Upgrade
|
| Free Cash Flow Per Share | 3.53 | 3.21 | 2.75 | 1.10 | 1.51 | 0.44 | Upgrade
|
| Dividend Per Share | 0.667 | 0.417 | 0.238 | 0.179 | 0.137 | 0.137 | Upgrade
|
| Dividend Growth | 180.01% | 75.01% | 33.31% | 29.99% | 0% | 40.06% | Upgrade
|
| Gross Margin | 37.99% | 37.89% | 39.25% | 40.08% | 37.74% | 38.85% | Upgrade
|
| Operating Margin | 9.00% | 8.91% | 9.69% | 8.99% | 9.06% | 8.08% | Upgrade
|
| Profit Margin | 6.36% | 6.25% | 6.35% | 5.79% | 5.66% | 5.29% | Upgrade
|
| Free Cash Flow Margin | 18.02% | 17.19% | 16.76% | 8.63% | 13.29% | 4.90% | Upgrade
|
| EBITDA | 2,340 | 2,210 | 2,115 | 1,521 | 1,303 | 925.25 | Upgrade
|
| EBITDA Margin | 9.90% | 9.79% | 10.63% | 9.93% | 9.91% | 9.00% | Upgrade
|
| D&A For EBITDA | 211.51 | 197.97 | 186.98 | 143.94 | 111.4 | 94.72 | Upgrade
|
| EBIT | 2,129 | 2,012 | 1,928 | 1,377 | 1,191 | 830.53 | Upgrade
|
| EBIT Margin | 9.00% | 8.91% | 9.69% | 8.99% | 9.06% | 8.08% | Upgrade
|
| Effective Tax Rate | 23.17% | 22.41% | 24.18% | 25.95% | 25.54% | 25.23% | Upgrade
|
| Revenue as Reported | 23,644 | 22,588 | 19,886 | 15,326 | 13,145 | 10,276 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.